FDA chief Gottlieb ‘names and shames’ big pharma for delaying generic competition
When Dr. Scott Gottlieb, commissioner of the Food and Drug Administration, publicly listed pharmaceutical companies that have “potentially blocked access” to samples of their branded products to generic drug developers —...To view the full article, register now.
Already a subscriber? Click here to view full article